Written and maintained by CASRAI Editorial Board
Last updated
This page describes products and general use; it is not medical advice.
A medical device distribution agreement is the contract under which a manufacturer or importer supplies devices to a distributor for resale to clinics, hospitals, laboratories or other buyers. This page is written for buyers, procurement staff, clinic managers and students who need to see which US federal rules sit behind the clauses in such an agreement. Exclusive, sole and non-exclusive territory terms are covered separately in the distributor agreement guide, so they are not repeated here.
What a medical device distribution agreement is
It is a supply-and-resale contract: it names the products, the parties’ roles, the territory and term, and what each side must do about labeling, complaints, records and recalls. The same document is searched for as a distribution agreement, a medical device distributor agreement, a distributor agreement template, or an exclusive distribution agreement for a medical device. They are one contract type; the wording changes with the deal, not the category. Who uses it: manufacturers and importers appointing distributors, distributors, and buyers who ask a supplier what documents sit behind a product. For wholesaler basics see medical supply wholesaler.
Which role you hold under 21 CFR 807.3
FDA’s establishment-registration rule defines roles by what a company does, not by what the contract calls it. A clause that changes the activity can change the role. The definitions below are from 21 CFR 807.3.
| Role | What 21 CFR 807.3 says | What it means for the contract |
|---|---|---|
| Initial importer | Any importer who furthers the marketing of a device from a foreign manufacturer and does not repackage or change the container, wrapper or labeling (807.3(g)). | The party bringing a foreign-made device into the US market is a distinct role from the downstream distributor. |
| Wholesale distributor | A person, other than the manufacturer or the initial importer, who distributes a device from the original place of manufacture to the person who makes the final delivery or sale to the ultimate consumer or user (807.3(t)). | A distributor that only resells the device as received fits this definition. |
| Repackaging or relabeling | Repackaging, or otherwise changing the container, wrapper or labeling of a device package in furtherance of distribution, is included in the definition of manufacture (807.3(d)(1)). | A private-label or relabeling clause can move a distributor out of the distributor role. |
| Specification initiator | Initiating specifications for devices that a second party manufactures, for later commercial distribution by the person who initiated them, is also manufacture (807.3(d)(3)). | A brand owner who sets specifications for a contract manufacturer is treated as a manufacturer; see contract manufacturing for medical devices. |
Section 807.3 does not define a standalone term “distributor”; the closest defined term is “wholesale distributor”. “Commercial distribution” means any distribution of a device intended for human use that is held or offered for sale, subject to the exclusions listed in the section (807.3(b)).
Clauses and the rule behind each
The table ties common clauses to text a buyer can read. Only the complaint-file rule (21 CFR 803.18(d)) is a duty the regulation places directly on distributors; the other rows are about role or are contractual practice reported by industry commentary.
| Clause topic | What the source says | Source |
|---|---|---|
| Role and definitions | Define whether each party is the manufacturer, initial importer or wholesale distributor, using the 807.3 definitions. | 21 CFR 807.3 |
| Relabeling and private label | Repackaging or changing labeling counts as manufacture, so the clause should say who may change labeling. | 21 CFR 807.3(d) |
| Complaint handling | A distributor must establish and maintain device complaint records (files), including any written, electronic or oral incident information it received or created alleging problems with a device’s identity, quality, safety or performance, and its evaluation of the allegation. | 21 CFR 803.18(d)(1) |
| Record retention | Copies of the incident records are kept for 2 years from the date added to the file, or the expected life of the device if that is longer, even if the distributor no longer distributes the device. | 21 CFR 803.18(d)(2) |
| Record location | The complaint files are maintained at the distributor’s principal business establishment. | 21 CFR 803.18(d)(3) |
| FDA access | The distributor must permit any authorized FDA employee, at all reasonable times, to access, copy and verify the records. | 21 CFR 803.18(d)(3) |
| Supplier controls, distribution records, storage, nonconforming product, recall support | Industry commentary says distributors are generally held to FDA requirements indirectly, through manufacturers’ supplier controls, that manufacturers should assess distributors’ records, storage, nonconforming product and customer feedback handling, and that recall handling belongs in a quality agreement. This is commentary, not a regulation. | UL Solutions (Emergo), industry commentary |
Complaint files and records under 21 CFR 803.18
For a distributor, the complaint-file rule is the clearest direct obligation placed on distributors. The file must be labeled and organized by device, and electronic files must be backed up. In a distribution agreement this usually becomes four practical points: how a complaint reaches the party that evaluates it, who keeps copies, how long copies are kept after the relationship ends, and how an FDA records request is handled. The retention rule runs past termination, so a termination clause that returns or destroys files at the end of the agreement can conflict with it. Importers are covered by separate medical device reporting event-file rules in 21 CFR 803, and the written procedures requirement in 803.17 names user facilities, importers and manufacturers; keep distributor and importer duties separate when reading a contract. See also complaint handling for medical devices.
Exclusive agreements and distributor templates
An exclusive distribution agreement for a medical device adds territory and performance terms, but the roles and the complaint-file rule above are defined by what each party does, not by whether the territory is exclusive. A distributor agreement template can list headings, but it cannot tell you which role each party holds in your deal. For the exclusivity terms, read the distributor agreement guide; for a general supply contract see supply agreement template for medical supplies.
How to compare suppliers’ documents
Limited to the regulation text cited on this page, a buyer or procurement reviewer can ask a supplier or distributor for:
- A statement of which role it holds for the product (initial importer, wholesale distributor, or a party that relabels).
- Its written procedure for receiving and recording device complaints, and where the complaint file is kept.
- The retention period it applies to complaint records.
- Confirmation that records are available to FDA on request.
A broader onboarding list is in vendor onboarding documentation checklist, and rules on tracking are in medical device tracking requirements.
Common mistakes
- Treating “distributor” in the contract title as the regulatory role. Roles follow activity under 807.3.
- Letting a private-label or relabeling clause pass without checking who becomes the manufacturer.
- Ending record retention at termination, when 803.18(d)(2) continues after the distributor stops distributing the device.
- Assuming a template’s headings settle the regulatory allocation. They do not.
- Overlooking assignment: see assignment clause in vendor contracts.
FAQ
What is a medical device distribution agreement?
It is the contract between a manufacturer or importer and a distributor covering the products, territory, term and each party’s duties for labeling, complaints, records and recalls.
Is there a medical device distributor agreement template?
Templates exist, but a template does not decide which role each party holds under 21 CFR 807.3. Use the role table above first, then the clause list.
What does an exclusive distribution agreement for a medical device change?
It changes territory and performance terms. Under the regulation text, roles and the distributor complaint-file duty depend on activity, not on exclusivity.
What records must a US distributor keep?
Device complaint files with incident information and the distributor’s evaluation, kept for 2 years or the expected life of the device, whichever is longer, at its principal business establishment and open to FDA (21 CFR 803.18(d)).
Sources
Checked 2026-11-01.
- 21 CFR 807.3, definitions (Cornell LII mirror of the eCFR): https://www.law.cornell.edu/cfr/text/21/807.3
- 21 CFR 803.18, recordkeeping by importers and distributors: https://www.law.cornell.edu/cfr/text/21/803.18
- 21 CFR 803.17, written MDR procedures: https://www.law.cornell.edu/cfr/text/21/803.17
- UL Solutions (Emergo), US medical device distributors: FDA expectations (industry commentary): https://www.emergobyul.com/news/us-medical-device-distributors-fda-expectations-distributors-and-manufacturers
